Catherine Ellis is a Director in Life Sciences within the Healthcare practice primarily assisting medical device and technology clients in both developed and emerging markets. She works with a variety clients of different sizes—from global corporations to smaller single technology companies. With expertise in both acute and post-acute settings, she collaborates with clients to assess growth opportunities, develop business and market access strategies, and provide commercial support, including due diligence, market assessment and development, forecasting, portfolio analysis, and competitive intelligence.
Select engagement experience includes:
Performed a market opportunity assessment for a coronary and peripheral endovascular device, determined potential usage given current/pipeline competitors and comparative clinical evidence, and built a forecast model to assist in acquisition pricing
Scanned the post-acute healthcare marketplace and identified potential acquisition candidates that best fit the client’s objectives and capabilities
Conducted a market opportunity assessment for a wireless vital sign measurement device under development, assessing potential for adoption, identifying key success requirements, developing targets, exploring partnership possibilities, and detailing commercialization requirements/investment
With growth in the US slowing as purchasing dynamics shift, many clients are seeking to establish their products in geographies outside the United States. Catherine helps clients understand and navigate the host of clinical, economic, infrastructural, and environmental barriers involved in entering OUS markets.
Conducted a global opportunity assessment for an emergency IV device, assessing IV utilization practices and protocols in different markets, sizing the ER and ambulance populations and vehicles in various geographies, identifying key protocol and purchase influencers, and modeling potential size and growth both inside and outside the hospital
Analyzed multiple geographies to develop specific strategies and tactics to expand utilization of specific surgical devices
Identified the optimal OUS markets for a client’s initial product launch based on regulatory climate, reimbursement environment, and clinical practice
One of Catherine’s many professional interests involves considering how innovative digital technologies are changing the role and value of medical devices, either by adding information capture and analysis to traditional devices or by replacing traditional devices entirely. She believes that the who, what, when, where, and why of patient monitoring and assessment is changing significantly and promises to fundamentally alter the delivery of healthcare.
Prior to joining Navigant/Easton Associates, Catherine worked for many years at Booz Allen & Hamilton and then as an independent consultant collaborating on strategic and organizational projects, as well as business assessment and acquisition analysis. She received her MBA with honors from Colombia Business School and is also a certified Advanced EMT.
M.B.A., Colombia University, Beta Gamma Sigma Honor Society B.A., Williams College